Contribution Rate Stabilisation Act
What the BStabG means for your medical aid billing
December is always a busy month for medical supply stores, with prescriptions piling up. This year, there is something extra to deal with: the GKV Contribution Rate Stabilisation Act (GKV-Beitragssatzstabilisierungsgesetz, BStabG). The BStabG brings two major changes for medical aids. For invoices that reach the statutory health insurance fund in full after 31 December 2026, the fund will deduct a flat 3%. At the same time, statutory co-payments will rise to a minimum of €7.50 and a maximum of €15 from 1 January 2027.
By adapting your billing, software and processes now, you protect your cash flow and avoid errors at the turn of the year. This article explains exactly what applies, which special cases you need to consider and which steps to complete by when. You can also follow all the latest developments in our live ticker on the Contribution Rate Stabilisation Act (in German).
Key points at a glance
- In 2027 and 2028, statutory health insurance funds will deduct a flat 3% from the invoice amount for medical aids.
- What counts is when the complete invoice (paper documents and data record) reaches the health insurance fund or its data acceptance centre, not the prescription date or the date of supply.
- Providers continue to invoice the full contractually agreed prices. They must not reduce individual line items themselves.
- From 1 January 2027, the co-payment for medical aids will be at least €7.50 and at most €15. For consumable medical aids, it is capped at €15 for a full month’s supply.
- For certain special cases, the implementation agreement allows a surcharge of 3.09%. This must be checked contract by contract.
What is the BStabG and what changes for medical aids?
The GKV Contribution Rate Stabilisation Act (BStabG) is a cost-cutting law for Germany’s statutory health insurance system. The Bundestag and Bundesrat passed it in July 2026. Its aim is to keep contribution rates stable by limiting spending. To achieve this, it spreads the burden across insured persons, healthcare providers, the pharmaceutical industry and the federal budget.
Two points are key for the supply of medical aids:
- a flat 3% deduction from the reimbursement for medical aids and nursing aids in 2027 and 2028,
- higher statutory co-payments for insured persons from 1 January 2027.
The changes affect all providers that bill statutory health insurance funds for medical aids: medical supply stores, homecare providers, orthopaedic technicians, rehabilitation technology providers and medical technology companies that supply patients directly. The changeover mainly affects billing, IT, accounting and customer service.
How does the 3% deduction on medical aids work?
The health insurance fund reduces the total amount of each invoice by a flat 3%. Providers do not change their prices. They continue to invoice the full contractually agreed prices and transmit them unchanged.
In practice, this means for your billing:
- Do not reduce any individual line item because of the 3% deduction.
- For consolidated invoices, the fund reduces the total invoice amount, not each line item.
- Co-payments and patient contributions are still calculated on the basis of the full contract price.
- Your billing software and billing service provider must be set up to transmit the contract prices unchanged.
As a result, several deductions will appear side by side in your incoming payments. According to the working paper, they are applied in this order: the fund’s review and any adjustments, a deduction under Section 303 SGB V for non-electronic submission where applicable, then the flat 3% deduction and, where applicable, an early payment discount. To ensure your accounting team can trace every reduction, your payment reconciliation should show these items separately.
Which cut-off date applies to the deduction?
What matters is when the complete invoice reaches the health insurance fund or its data acceptance centre. If the complete invoice arrives on or before 31 December 2026, no deduction applies. If it arrives on or after 1 January 2027, the fund deducts 3%.
| Criterion | Relevant for the deduction? |
|---|---|
| Receipt of the complete invoice (paper documents and data record) by the fund or its data acceptance centre | Yes |
| Prescription date | No |
| Supply period or delivery date | No |
| Dispatch date at the provider or billing service provider | No |
“Complete” means that both the paper documents and the data record under Section 302 SGB V must have arrived. If either is missing on 31 December 2026, the invoice falls into 2027.
What this means for you:
- Clear your backlog of prescriptions and invoices now and resolve any outstanding cases.
- Wherever possible, deliver and invoice high-value supplies, such as prosthetics, before the end of 2026.
- Ask your billing service provider, for example Opta Data or Optica, for its December submission deadline.
- If necessary, book an express courier for 30 and 31 December and keep the proof of delivery.
How will co-payments for medical aids change from 2027?
From 1 January 2027, statutory co-payments for medical aids will increase by 50%. Insured persons will still pay 10% of the cost, but at least €7.50 and at most €15, and never more than the medical aid itself costs.
| Co-payment | Until 31 Dec 2026 | From 1 Jan 2027 |
|---|---|---|
| Minimum per medical aid | €5 | €7.50 |
| Maximum per medical aid | €10 | €15 |
| Consumable medical aids (Section 33(8) SGB V) | 10%, capped at €10 for a month’s supply | 10%, capped at €15 for a month’s supply |
Consumable medical aids are items that are needed again and again, such as insulin syringes, disposable gloves or absorbent bed pads. Children and young people under the age of 18 remain exempt from co-payments.
What this means for your business:
- Update the co-payment logic in your software to the new amounts with effect from 1 January 2027.
- Continue to calculate co-payments and patient contributions on the basis of the full contract price, not the amount after the deduction.
- To determine whether the old or new amounts apply, the working paper refers to the prescription date or the date of service. Check this against your contracts and your billing software.
- Brief your customer service team and branches in good time, as patients will ask about the higher amounts.
Which special cases apply under the BStabG?
Not every item is treated the same way. For some cases, the implementation agreement sets out specific rules. Others require a separate invoice.
| Special case | What applies | What to do |
|---|---|---|
| Third-party invoices passed on without a mark-up | possible surcharge of 3.09% from 1 January 2027 to 31 December 2028 | check contract by contract and map the original invoice correctly |
| Fixed-amount supplies in product group 08 (insoles) and 17 (compression therapy aids) | possible surcharge of 3.09% | clarify with your contractual partners and enter prices with start and end dates |
| Separately agreed flat-rate collection fees | possible surcharge of 3.09% | adjust your invoicing and posting logic |
| Products and services outside the supply of medical aids and nursing aids | no deduction | issue a separate invoice, do not include them in a consolidated invoice with medical aids |
| Items with different VAT rates | tax treatment of the flat-rate reduction still open | consider separate invoices and agree the tax treatment with your tax adviser |
Important: According to the working paper, the 3.09% surcharge is not clearly set out in SGB V but forms part of the implementation agreements. Before you apply it, agree the basis, calculation and presentation with your contractual partners in a binding manner.
What do medical supply stores need to do now?
You can plan the changeover in four phases: prepare, adapt processes and systems, test, and then monitor in day-to-day operations. The first phase should start immediately and no later than November 2026.
| Phase | Timeframe | Key tasks |
|---|---|---|
| 1. Prepare | immediately, no later than November 2026 | responsibilities, billing channels, contracts, special cases |
| 2. Adapt processes and systems | by mid-December 2026 | software, co-payments, invoicing logic, payment reconciliation, staff briefing |
| 3. Test and approve | before the first billing run in 2027 | test cases, consolidated invoices, special cases, sign-off |
| 4. Day-to-day operations | from the first billing run in 2027 | track receipt, reconcile payments, resolve discrepancies |
Phase 1: Prepare and assign responsibilities
- Appoint a project lead and involve billing, IT and software, contract management, accounting and the relevant supply areas.
- Record all billing channels under Section 302 SGB V, both direct and via service providers. For each fund, document the data acceptance centre and the route for paper documents.
- Let M Assist know early if you need support. As every company has to make the changeover at the same time, it is first come, first served.
- Check which prescriptions can be billed, clear your backlog of prescriptions and invoices, resolve outstanding cases and deliver and invoice high-value supplies, such as prosthetics, before the end of 2026.
- Compile your contracts and billing rules for each payer. Note any deviations, outstanding implementation agreements and questions for funds or billing service providers, and feel free to send them to M Assist promptly.
- Identify special cases: third-party invoices passed on without a mark-up, fixed-amount supplies in PG 08 and PG 17, separately agreed flat-rate collection fees, and products and services outside the supply of medical aids and nursing aids.
- For mixed invoices, define which items require a separate invoice. Where different VAT rates apply, consider issuing separate invoices.
- Check the possible 3.09% surcharge for each contract and implementation agreement, agree the basis, calculation and presentation with your contractual partners, and enter new prices with start and end dates.
- Agree the tax treatment of the flat-rate reduction for the different VAT cases with your tax adviser and document it internally. M Assist will provide an IT implementation proposal for this.
Phase 2: Adapt processes and systems
- Make sure your software and service providers transmit the full contract prices.
- Make the receipt of complete invoices by the fund traceable, including for consolidated invoices.
- Update the co-payment logic to the amounts applicable from 1 January 2027.
- Set up invoicing and posting logic for special cases: original invoices for third-party invoices passed on without a mark-up, separate flat-rate collection fees and agreed fixed-amount and pricing rules. Build separate invoicing into your workflows so that items outside the scope do not end up in a consolidated invoice with medical aids by mistake.
- Set up payment reconciliation so that the 3% reduction, adjustments, deductions under Section 303 SGB V and early payment discounts are shown separately.
- Brief your billing team and customer service on the cut-off date, price transmission and new co-payments.
Phase 3: Test and approve the changeover
- Run test cases for invoices received on or before 31 December 2026 and on or after 1 January 2027, testing paper documents and data records both separately and together.
- Test consolidated invoices, co-payment cases with a month’s supply, rounding and patient contributions.
- Test special cases: third-party invoices, flat-rate collection fees, PG 08 and PG 17, items outside the scope and different VAT rates. Test billing via service providers end to end: transmission, proof of complete receipt, feedback from the fund, adjustments and payment reconciliation.
- Document the results and record sign-off by billing, IT and accounting.
Phase 4: Day-to-day operations from 1 January 2027
- Continue to invoice and transmit the agreed prices unchanged.
- For every affected invoice, track complete receipt by the fund or data acceptance centre. Resolve incomplete or late submissions promptly.
- Reconcile incoming payments in the expected order.
- Document discrepancies, unexplained reductions and cases without separate information from the fund, and resolve them through the contractual or established channels.
- Adapt your processes whenever the law, contracts, implementation agreements or fund practice change, and inform the employees and service providers concerned.
You can download the full checklist, with fields for responsibilities, deadlines and evidence, from our page on the Contribution Rate Stabilisation Act (in German).
How does M Assist support the changeover?
We support medical supply stores and homecare providers in adapting their billing, software and processes. This includes clarifying questions about contracts and health insurance funds, as well as an IT implementation proposal for the co-payment logic and the tax treatment of the reduction. There is also a dedicated software implementation supplement for KUMAVISION Healthcare365 and Maptara.
As all companies are under pressure to make the changeover at the same time, it is first come, first served. Please register your support requirements early and on a binding basis using our BStabG support form. 50% of the agreed scope is fixed; the rest is only charged if the work is actually carried out.
Frequently asked questions about the BStabG and medical aids
When does the 3% deduction on medical aids apply?
The 3% deduction applies to invoices that reach the health insurance fund or its data acceptance centre in full on or after 1 January 2027. It is limited to 2027 and 2028.
Do I have to reduce my prices on the invoice by 3% myself?
No. Providers continue to invoice the full contractually agreed prices. The health insurance fund applies the deduction as a flat rate to the total invoice amount.
Does the BStabG go by the prescription date or the delivery date?
Neither. For the deduction, the only thing that counts is when the complete invoice, meaning the paper documents and the data record, reaches the fund. For the new co-payment amounts, however, the working paper refers to the prescription date or the date of service.
How high is the co-payment for medical aids from 2027?
From 1 January 2027, insured persons pay 10% of the cost, at least €7.50 and at most €15 per medical aid. For consumable medical aids, they pay 10%, capped at €15 for a full month’s supply.
Is the co-payment calculated on the reduced or the full price?
On the full contract price. The fund’s flat-rate deduction does not change how co-payments and patient contributions are calculated.
What applies to services that are not medical aids?
Products and services outside the supply of medical aids and nursing aids are not reduced. However, they require a separate invoice and must not be included in a consolidated invoice with medical aids.
What is the 3.09% surcharge?
Under the implementation agreement, a surcharge of 3.09% may be applied from 1 January 2027 to 31 December 2028 to third-party invoices, fixed-amount supplies in product groups 08 and 17, and separately agreed flat-rate collection fees. It offsets the deduction in these cases and must be checked contract by contract.
Conclusion: Make the changeover now, before the year-end rush
The BStabG changes the billing of medical aids in several areas at once: the deduction, the cut-off date, co-payments and special cases. If you adapt your software and processes by mid-December 2026 and test them before the first billing run in 2027, you will get through the turn of the year safely. Above all, make sure you transmit contract prices unchanged and track the complete receipt of every invoice.
We support you every step of the way, from planning to implementation in your software. For the latest changes, the downloadable checklist and all key dates, visit our live ticker on the Contribution Rate Stabilisation Act (in German).
Request support nowNote: This article is a practical guide based on the working paper of 12 November 2026 and does not constitute legal or tax advice. Responsibility for implementation lies with the provider. The working paper is being updated on an ongoing basis, and we will update this article whenever changes occur.
Sources
- M Assist: Live ticker on the Contribution Rate Stabilisation Act, as of 12 November 2026 (in German)
- M Assist: Checklist for implementing the changes to the supply of medical aids, as of 12 November 2026 (in German)
- AOK: GKV Contribution Rate Stabilisation Act, legislative process (in German)
- German Bundestag: Government bill, printed paper 21/6130 (in German)
- GKV-Spitzenverband: Press release of 27 July 2026 on medical aids and co-payments (in German)
- Verbraucherzentrale: Medical aids – who pays which costs?, as of 17 September 2026 (in German)



